Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders
- PMID: 29595814
- DOI: 10.1038/gim.2018.39
Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders
Abstract
Purpose: Whole-exome sequencing (WES) has revolutionized Mendelian diagnostics, however, there is no consensus on the timing of data review in undiagnosed individuals and only preliminary data on the cost-effectiveness of this technology. We aimed to assess the utility of WES data reanalysis for diagnosis in Mendelian disorders and to analyze the cost-effectiveness of this technology compared with a traditional diagnostic pathway.
Methods: WES was applied to a cohort of 54 patients from 37 families with a variety of Mendelian disorders to identify the genetic etiology. Reanalysis was performed after 12 months with an improved WES diagnostic pipeline. A comparison was made between costs of a modeled WES pathway and a traditional diagnostic pathway in a cohort with intellectual disability (ID).
Results: Reanalysis of WES data at 12 months improved diagnostic success from 30 to 41% due to interim publication of disease genes, expanded phenotype data from referrer, and an improved bioinformatics pipeline. Cost analysis on the ID cohort showed average cost savings of US$586 (AU$782) for each additional diagnosis.
Conclusion: Early application of WES in Mendelian disorders is cost-effective and reanalysis of an undiagnosed individual at a 12-month time point increases total diagnoses by 11%.
Keywords: Mendelian; cost-effectiveness; diagnosis; exome; genomics.
Similar articles
-
Improved Diagnostic Yield in Recessive Intellectual Disability Utilizing Systematic Whole Exome Sequencing Data Reanalysis.Clin Genet. 2025 Jun;107(6):612-619. doi: 10.1111/cge.14692. Epub 2025 Jan 2. Clin Genet. 2025. PMID: 39748273
-
Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness.Genet Med. 2019 Jan;21(1):173-180. doi: 10.1038/s41436-018-0006-8. Epub 2018 May 15. Genet Med. 2019. PMID: 29765138
-
Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability.Genet Med. 2016 Sep;18(9):949-56. doi: 10.1038/gim.2015.200. Epub 2016 Feb 4. Genet Med. 2016. PMID: 26845106
-
Making headway with genetic diagnostics of intellectual disabilities.Clin Genet. 2014 Feb;85(2):101-10. doi: 10.1111/cge.12244. Epub 2013 Aug 26. Clin Genet. 2014. PMID: 23895455 Review.
-
Exome sequencing greatly expedites the progressive research of Mendelian diseases.Front Med. 2014 Mar;8(1):42-57. doi: 10.1007/s11684-014-0303-9. Epub 2014 Jan 3. Front Med. 2014. PMID: 24384736 Review.
Cited by
-
Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis.Eur J Hum Genet. 2022 Oct;30(10):1121-1131. doi: 10.1038/s41431-022-01162-2. Epub 2022 Aug 15. Eur J Hum Genet. 2022. PMID: 35970915 Free PMC article.
-
Genetic tests by next-generation sequencing in children with developmental delay and/or intellectual disability.Clin Exp Pediatr. 2020 Jun;63(6):195-202. doi: 10.3345/kjp.2019.00808. Epub 2019 Nov 4. Clin Exp Pediatr. 2020. PMID: 32024334 Free PMC article.
-
Genome-Wide Sequencing Modalities for Children with Unexplained Global Developmental Delay and Intellectual Disabilities-A Narrative Review.Children (Basel). 2023 Mar 3;10(3):501. doi: 10.3390/children10030501. Children (Basel). 2023. PMID: 36980059 Free PMC article. Review.
-
Overgrowth Syndromes-Evaluation, Diagnosis, and Management.Front Pediatr. 2020 Oct 30;8:574857. doi: 10.3389/fped.2020.574857. eCollection 2020. Front Pediatr. 2020. PMID: 33194904 Free PMC article. Review.
-
Children's rare disease cohorts: an integrative research and clinical genomics initiative.NPJ Genom Med. 2020 Jul 6;5:29. doi: 10.1038/s41525-020-0137-0. eCollection 2020. NPJ Genom Med. 2020. PMID: 32655885 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical